Mergers & Acquisitions in the Cannabis Industry
Mergers and acquisitions in any industry are difficult, but in the cannabis industry, they’re even more so. There are a number of things in mergers and acquisitions that business, buyers, and sellers need to be aware of that they aren’t typically aware of in other industries. Due diligence is important prior to a cannabis transaction. It’s even more so given the history of how cannabis has grown up in the various states, and to know more about the person you’re buying your company from.
The second issue has to do with the ownership structures that particular states allow in the cannabis industry. Each state is unique, each state has its own rules, each state has its own way of interpreting its own rules, and in each state, there are certain types of people who either cannot own a cannabis business, or there are particular ways they can own a cannabis business, and these can create very complicated ownership structures, and makes it difficult for cannabis companies to raise capital.
The third issue that people need to be aware of in mergers and acquisitions is how to value a cannabis business, whether it’s a licensed cannabis business or an ancillary cannabis business. The industry has not been around for very long, so how the market values each particular business does not have much history. Typically, in the state of Colorado, businesses are sold on a multiple of earnings, but that can change from place to place, location also matters, and other states don’t have much history at all of buying and selling of cannabis businesses. And there’s also the problem that there are very few publicly traded cannabis businesses, so there are no public markets for anybody to tell valuations of cannabis businesses.
At McAllister Garfield, we’ve handled hundreds of mergers and acquisitions in the cannabis industry, both for licensed cannabis businesses, and for ancillary businesses, and we can help you with yours as well.
Related Article
Psychedelic Therapy & Law Update – April 2026
President Trump to Issue Executive Order on Ibogaine President Trump will sign an executive order opening doors for more federal reserach on ibogaine, the naturally occuring psychedelic substance with indigenous roots in Africa. For more information, see this article by clicking here. Ibogaine has shown significant benefits for veterans suffering from war trauma, those suffering from […]
Psychedelic Therapy & Law Update – March 2026
Colorado starts the rulemaking process again for NMHA program changes DOR Natural Medicine Division is proposing several rules changes to the NMHA rules. These proposed changes include a significant increase in the cost of standard healing center licenses (from $6k to over $10k). Other proposed changes include adding an owner entity fee, prohibiting cultivator sampling […]
Psychedelic Therapy & Law Update – February 2026
Maryland and New Jersey moving toward creation of psilocybin programs The Maryland Task Force on Responsible Use of Natural Psychedelic Substances, in a report near the end of 2025 endorsed the creation of a regulated psilocybin program in the state. The recommendation still needs to be adopted by the Maryland legislature, but this is an […]